We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

37 hedge funds and large institutions have $43.9M invested in InVivo Therapeutics Holdings Corp in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

438% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $879K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more funds holding

Funds holding: 35 → 37 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

34% less capital invested

Capital invested by funds: $66.6M → $43.9M (-$22.7M)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
1
Closed
4
Calls
$4.73M
Puts
$879K
Net Calls
+$3.85M
Net Calls Change
+$4.41M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$3.04M
2
Northern Trust
Northern Trust
Illinois
+$2.57M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.1M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$4.01M
2
CSS
Cubist Systematic Strategies
Connecticut
-$344K
3
Jane Street
Jane Street
New York
-$277K
4
Bank of America
Bank of America
North Carolina
-$234K
5
EIM
Emerson Investment Management
Massachusetts
-$234K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$173K +$234K +1 New
MLICM
27
Metropolitan Life Insurance Company (MetLife)
New York
$159K – – –
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$159K – – –
AIG
29
American International Group
New York
$149K – – –
NFA
30
Nationwide Fund Advisors
Ohio
$147K – – –
VOYA Investment Management
31
VOYA Investment Management
Georgia
$125K – – –
BA
32
BlackRock Advisors
Delaware
$112K – – –
HKIM
33
Hayek Kallen Investment Management
Alabama
$95K – – –
CS
34
Credit Suisse
Switzerland
$94K – – –
Cambridge Investment Research Advisors
35
Cambridge Investment Research Advisors
Iowa
$91K +$234K +1 New
PG
36
PEAK6 Group
Illinois
$82K +$234K +1 New
Bank of America
37
Bank of America
North Carolina
$78K -$234K -1 Closed
SO
38
STRS Ohio
Ohio
$73K – – –
Wells Fargo
39
Wells Fargo
California
$68K – – –
Deutsche Bank
40
Deutsche Bank
Germany
$63K – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$51.5K – – –
Creative Planning
42
Creative Planning
Kansas
$39K – – –
LTFS
43
Ladenburg Thalmann Financial Services
Florida
$36K – – –
Simplex Trading
44
Simplex Trading
Illinois
$17K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$16K – – –
Citadel Advisors
46
Citadel Advisors
Florida
$13K – – –
TRCT
47
Tower Research Capital (TRC)
New York
$11K – – –
Group One Trading
48
Group One Trading
Illinois
$9K – – –
BlackRock
49
BlackRock
New York
$6K – – –
Bessemer Group
50
Bessemer Group
New Jersey
$3K – – –
1
2
3

NVIV Hedge Fund Activity: Q3 2015 in Review

37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q3 2015, worth a combined $43.9M — down 34% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.01M sold.

  • 37 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q3 2015, up from 35 in Q2 2015.
  • Funds reported $43.9M of InVivo Therapeutics Holdings Corp stock for Q3 2015, down 34% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q3 2015 and 4 closed out, a net change of +2 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $3.04M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q3 2015 was Bogle Investment Management, an estimated $4.01M sold.

Based on aggregated 13F filings for Q3 2015.